Nicola Stefano Fracchiolla

24PUBLICATIONS
283CO-AUTHORS
NanomedicineMedical virologyGene and molecular therapyCardiology (incl. cardiovascular diseases)Respiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Aug 17, 2026
Real-world outcomes of venetoclax plus hypomethylating agents in unfit acute myeloid leukaemia: Results of the GIMEMA AML2320 trial.

|Mar 19, 2026
Underrated, Unvaccinated, Untreated: A Multinational Registry Analysis of Human Metapneumovirus in Hematological Malignancy, Insights From EPICOVIDEHA/EPIRESEHA Registry.

Jon Salmanton-García, Francesco Marchesi, Erica Mackenzie

|Jan 13, 2026
NPM1 and IDH1/2 Mutations Show Limited Prognostic Impact in Relapsed/Refractory AML: Evidence From the AVALON Cohort.

Calogero Vetro, Irene Azzali, Elisabetta Petracci

|Sep 24, 2025
Real World Study on the Best CPX-351 Treatment Duration and Timing for Allogeneic Stem Cell Transplantation.

Fabio Guolo, Luana Fianchi, Maria Paola Martelli

|Jan 20, 2025
Impact of Pre-Treatment Comorbidity Burden on Survival in Patients Receiving Venetoclax Plus Hypomethylating Agents.

Giovanni Marconi, Elisabetta Petracci, Giuseppe Lanzarone

|Dec 23, 2024
Respiratory Viruses in Patients With Hematological Malignancy in Boreal Autumn/Winter 2023-2024: EPICOVIDEHA-EPIFLUEHA Report.

Jon Salmanton-García, Francesco Marchesi, Milan Navrátil

Pageof 4

Frequent Collaborators

14 joint publications

Livio Pagano

13 joint publications

Francesco Marchesi

10 joint publications

Jon Salmanton-García

9 joint publications

Andreas Glenthøj